Page last updated: 2024-10-31

nafronyl and Cardiovascular Diseases

nafronyl has been researched along with Cardiovascular Diseases in 4 studies

Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"A retrospective analysis was performed on all five published clinical trials in which naftidrofuryl was given at a dosage of 600 mg daily."2.67Naftidrofuryl in intermittent claudication: a retrospective analysis. ( Brown, TM; Comte, S; Gamand, S; Lehert, P, 1994)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lehert, P1
Comte, S1
Gamand, S1
Brown, TM1
Pohlmann-Eden, B1
Linden, D1
Bergler, W1
Ducloux, G1
Marchand, X1
Laurent, JM1
Lecoutour, X1
Puech, F1
Delecour, M1

Trials

1 trial available for nafronyl and Cardiovascular Diseases

ArticleYear
Naftidrofuryl in intermittent claudication: a retrospective analysis.
    Journal of cardiovascular pharmacology, 1994, Volume: 23 Suppl 3

    Topics: Cardiovascular Diseases; Exercise; Female; Humans; Intermittent Claudication; Male; Middle Aged; Naf

1994

Other Studies

3 other studies available for nafronyl and Cardiovascular Diseases

ArticleYear
[Convulsive crises and cardiovascular complications following high-dosage parenteral administration of naftidrofuryl].
    Deutsche medizinische Wochenschrift (1946), 1991, Sep-20, Volume: 116, Issue:38

    Topics: Adult; Cardiovascular Diseases; Humans; Infusions, Intravenous; Male; Nafronyl; Seizures; Time Facto

1991
[Naftidrofuryl--a new direction in angiologic therapy. Symposium of the 17th annual meeting of the German Society of Angiology. Esslingen, 1988].
    VASA. Supplementum, 1988, Volume: 24

    Topics: Cardiovascular Diseases; Furans; Humans; Nafronyl

1988
[Cardiovascular complications due to naftidrofuryl].
    Annales de cardiologie et d'angeiologie, 1985, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Animals; Cardiovascular Diseases; Dogs; Female; Furans; Haplorhini; Humans;

1985